991891

Beutlich Pharmaceuticals LLC — FEI 1413399

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 4, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bunnell, FL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
200821 CFR 211.186(a)Written procedures followed
241921 CFR 211.198(a)Complaint Handling Procedure